However, as shown in figure 4A, ECD/Her2 immunization significantly prolonged tumor free survival in D2F2/E2 injected mice (day 58) compared to PBS immunized mice (day 31), (p < 0.01). The gene discussed is ERBB2; the disease is neoplasm.